Soleno Therapeutics ( NASDAQ: SLNO ) intends to offer and sell shares of its common stock in an underwritten public offering.
Nilanjana Basu is a correspondent specializing in local business news in India. She writes for Seeking Alpha and her work has also appeared in exchange4media. Nilanjana covers a wide range of topics including corporate appointments, financial announcements, and market updates.